지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2016.7
- 수록면
- 269 - 277 (9page)
이용수
초록· 키워드
오류제보하기
Background: The findings of currently available studies are not consistent with regard to the association between the risk of cancer and ginseng consumption. Therefore, we aimed to evaluate this association by conducting a meta-analysis of different studies.
Methods: To systematically evaluate the effect of ginseng consumption on cancer incidence, six databases were searched, including PubMed, Ovid Technologies, Embase, The Cochrane Library, China National Knowledge Infrastructure, and Chinese VIP Information, from 1990 to 2014. Statistical analyses based on the protocol employed for a systematic review were conducted to calculate the summary relative risks (RRs) and 95% confidence intervals (CIs).
Results: We identified nine studies, including five cohort studies, three case-control studies, and one randomized controlled trial, evaluating the association between ginseng consumption and cancer risk; these studies involved 7,436 cases and 334,544 participants. The data from the meta-analysis indicated a significant 16% lower risk of developing cancer in patients who consumed ginseng (RR = 0.84, 95% CI = 0.76-0.92), with evidence of heterogeneity (p = 0.0007, I² = 70%). Stratified analyses suggested that the significant heterogeneity may result from the incidence data for gastric cancer that were included in this study. Publication bias also showed the same result as the stratified analyses. In addition, subgroup analyses for four specific types of cancer (colorectal cancer, lung cancer, gastric cancer, and liver cancer) were also performed. The summary RRs for ginseng intake versus no ginseng consumption were 0.77 for lung cancer, 0.83 for gastric cancer, 0.81 for liver cancer, and 0.77 for colorectal cancer.
Conclusion: The findings of this meta-analysis indicated that ginseng consumption is associated with a significantly decreased risk of cancer and that the effect is not organ specific.
Methods: To systematically evaluate the effect of ginseng consumption on cancer incidence, six databases were searched, including PubMed, Ovid Technologies, Embase, The Cochrane Library, China National Knowledge Infrastructure, and Chinese VIP Information, from 1990 to 2014. Statistical analyses based on the protocol employed for a systematic review were conducted to calculate the summary relative risks (RRs) and 95% confidence intervals (CIs).
Results: We identified nine studies, including five cohort studies, three case-control studies, and one randomized controlled trial, evaluating the association between ginseng consumption and cancer risk; these studies involved 7,436 cases and 334,544 participants. The data from the meta-analysis indicated a significant 16% lower risk of developing cancer in patients who consumed ginseng (RR = 0.84, 95% CI = 0.76-0.92), with evidence of heterogeneity (p = 0.0007, I² = 70%). Stratified analyses suggested that the significant heterogeneity may result from the incidence data for gastric cancer that were included in this study. Publication bias also showed the same result as the stratified analyses. In addition, subgroup analyses for four specific types of cancer (colorectal cancer, lung cancer, gastric cancer, and liver cancer) were also performed. The summary RRs for ginseng intake versus no ginseng consumption were 0.77 for lung cancer, 0.83 for gastric cancer, 0.81 for liver cancer, and 0.77 for colorectal cancer.
Conclusion: The findings of this meta-analysis indicated that ginseng consumption is associated with a significantly decreased risk of cancer and that the effect is not organ specific.
목차
ABSTRACT
1. Introduction
2. Materials and methods
3. Results
4. Discussion
5. Conclusion
References
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Prediction of Cancer Incidence and Mortality in Korea, 2023
Cancer Research and Treatment
2023 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2022
Cancer Research and Treatment
2022 .04
-
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
-
암 치료성적 향상을 위한 제안
대한의사협회지
2017 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2021
Cancer Research and Treatment
2021 .01
-
Gastric Cancer
대한외과학회 학술대회 초록집
2022 .11
-
Prediction of Cancer Incidence and Mortality in Korea, 2016
Cancer Research and Treatment
2016 .01
-
Risk Factors and Epidemiology of Gastric Cancer in Pakistan
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2019
Cancer Research and Treatment
2019 .01
-
Prediction of Cancer Incidence and Mortality in Korea, 2017
Cancer Research and Treatment
2017 .01
-
Clinicopathologic Characteristics of Interval Gastric Cancer in Korea
Gut and Liver
2015 .01
-
Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
Cancer Research and Treatment
2019 .01
-
Health Beliefs Associated with Cancer Screening Intentions in Korean Workers
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Population-Based Regional Cancer Incidence in Korea: Comparison between Urban and Rural Areas
Cancer Research and Treatment
2016 .01
-
Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer
Investigative and Clinical Urology
2022 .03
-
한국의 암환자 치료와 관리현황
대한의사협회지
2017 .01
-
Updates on cancer epidemiology in Korea, 2018
전남의대학술지
2018 .01
-
Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer
Cancer Research and Treatment
2016 .01
-
Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2018-524-001598365